Ronald Asbury Andrews

CIK: 0001299153

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (10.0%)

Derivative conversions

Awards (A)14 (70.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CNSY

CERENOME, INC.

Director

PRPO

Precipio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (20 total)

CNSY
CERENOME, INC.
Oct 1, 2026
Exercise(M)
Direct
921 shares-
PSTV
PLUS THERAPEUTICS, INC.
Jul 1, 2026
Exercise(M)
Direct
922 shares-
PSTV
PLUS THERAPEUTICS, INC.
May 14, 2026
Award(A)
Restricted Stock Units
Direct
3.7K shares-
PSTV
PLUS THERAPEUTICS, INC.
May 14, 2026
Award(A)
Stock Option (Right to Buy)
Direct
1.6K shares-
PSTV
PLUS THERAPEUTICS, INC.
May 14, 2026
Award(A)
Stock Option (Right to Buy)
Direct
3.7K shares-
PRPO
Precipio, Inc.
Jan 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
1.5K shares-
PRPO
Precipio, Inc.
Oct 15, 2025
Award(A)
Direct
568 shares at avg. $17.58$10K
PRPO
Precipio, Inc.
Jul 16, 2025
Award(A)
Direct
676 shares at avg. $14.78$10K
PRPO
Precipio, Inc.
Apr 15, 2025
Award(A)
Direct
1.8K shares at avg. $5.60$10K
PRPO
Precipio, Inc.
Jan 15, 2025
Award(A)
Direct
1.6K shares at avg. $6.10$10K
PRPO
Precipio, Inc.
Jan 14, 2025
Award(A)
Stock Option (Right to Buy)
Direct
1K shares-
PRPO
Precipio, Inc.
Oct 15, 2024
Award(A)
Direct
1.5K shares at avg. $6.62$10K
PRPO
Precipio, Inc.
Aug 31, 2024
Disposition(D)
Stock Option (Right to Buy)
Direct
258 shares-
PRPO
Precipio, Inc.
Aug 31, 2024
Award(A)
Stock Option (Right to Buy)
Direct
258 shares-
PRPO
Precipio, Inc.
Aug 31, 2024
Disposition(D)
Stock Option (Right to Buy)
Direct
1.3K shares-
PRPO
Precipio, Inc.
Aug 31, 2024
Award(A)
Stock Option (Right to Buy)
Direct
1.3K shares-
PRPO
Precipio, Inc.
Aug 31, 2024
Disposition(D)
Stock Option (Right to Buy)
Direct
2K shares-
PRPO
Precipio, Inc.
Aug 31, 2024
Award(A)
Stock Option (Right to Buy)
Direct
2K shares-
PRPO
Precipio, Inc.
Aug 31, 2024
Award(A)
Stock Option (Right to Buy)
Direct
103 shares-
PRPO
Precipio, Inc.
Aug 31, 2024
Disposition(D)
Stock Option (Right to Buy)
Direct
103 shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	CNSY CERENOME, INC.	Exercise(M)	921	-	$0	Direct
Jul 1, 2026	PSTV PLUS THERAPEUTICS, INC.	Exercise(M)	922	-	$0	Direct
May 14, 2026	PSTV PLUS THERAPEUTICS, INC.	Award(A) Restricted Stock Units	3,686	-	-	Direct
May 14, 2026	PSTV PLUS THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	1,600	-	-	Direct
May 14, 2026	PSTV PLUS THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	3,686	-	-	Direct
Jan 2, 2026	PRPO Precipio, Inc.	Award(A) Stock Option (Right to Buy)	1,500	-	-	Direct
Oct 15, 2025	PRPO Precipio, Inc.	Award(A)	568	$17.58	$9,985	Direct
Jul 16, 2025	PRPO Precipio, Inc.	Award(A)	676	$14.78	$9,991	Direct
Apr 15, 2025	PRPO Precipio, Inc.	Award(A)	1,785	$5.60	$9,996	Direct
Jan 15, 2025	PRPO Precipio, Inc.	Award(A)	1,639	$6.10	$9,998	Direct
Jan 14, 2025	PRPO Precipio, Inc.	Award(A) Stock Option (Right to Buy)	1,000	-	-	Direct
Oct 15, 2024	PRPO Precipio, Inc.	Award(A)	1,510	$6.62	$9,996	Direct
Aug 31, 2024	PRPO Precipio, Inc.	Disposition(D) Stock Option (Right to Buy)	258	-	-	Direct
Aug 31, 2024	PRPO Precipio, Inc.	Award(A) Stock Option (Right to Buy)	258	-	-	Direct
Aug 31, 2024	PRPO Precipio, Inc.	Disposition(D) Stock Option (Right to Buy)	1,250	-	-	Direct
Aug 31, 2024	PRPO Precipio, Inc.	Award(A) Stock Option (Right to Buy)	1,250	-	-	Direct
Aug 31, 2024	PRPO Precipio, Inc.	Disposition(D) Stock Option (Right to Buy)	2,000	-	-	Direct
Aug 31, 2024	PRPO Precipio, Inc.	Award(A) Stock Option (Right to Buy)	2,000	-	-	Direct
Aug 31, 2024	PRPO Precipio, Inc.	Award(A) Stock Option (Right to Buy)	103	-	-	Direct
Aug 31, 2024	PRPO Precipio, Inc.	Disposition(D) Stock Option (Right to Buy)	103	-	-	Direct

1-20 of 20 transactions

About ANDREWS RONALD ASBURY

ANDREWS RONALD ASBURY (SEC CIK 0001299153) files insider reports with the SEC as Director of CERENOME, INC. (CNSY) and Director of Precipio, Inc. (PRPO).

Signal8 holds 13 ownership filings by ANDREWS RONALD ASBURY (1 Form 3, 12 Form 4), filed between Sep 6, 2024 and Oct 1, 2026. Those filings report 20 transactions, from Aug 31, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on ANDREWS RONALD ASBURY's filings is in HOUSTON, TX.

Recent filings by ANDREWS RONALD ASBURY

Oct 1, 2026: Option exercise of CNSY shares (Form 4, code M).
Jul 1, 2026: Option exercise of PSTV shares (Form 4, code M).
May 14, 2026: Grants or awards of PSTV derivative securities (3 lines, Form 4, code A).
Jan 2, 2026: Grant or award of PRPO derivative securities (Form 4, code A).
Oct 15, 2025: Grant or award of PRPO shares (Form 4, code A).

Other insiders filing for CERENOME, INC. (CNSY)

van Es-Johansson An, Director
Hawkins Richard J, Director
Clowes Howard, Director
Sims Andrew John Hugh MacIntyre, Chief Financial Officer
HEDRICK MARC H, Chief Executive Officer
Guse Kyle, Director

How to read Form 4 transaction codes